Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa

Eitemau Tebyg

• Immunomodulatory Clarithromycin Treatment of Experimental Sepsis and Acute Pyelonephritis Caused by Multidrug-Resistant Pseudomonas aeruginosa
  gan: Giamarellos-Bourboulis, Evangelos J., et al.
  Cyhoeddwyd: (2004)
• Clarithromycin reverses sepsis-induced immunoparalysis of monocytes
  gan: Raftogiannis, M, et al.
  Cyhoeddwyd: (2009)
• Effect of Clarithromycin in Inflammatory Markers of Patients with Ventilator-Associated Pneumonia and Sepsis Caused by Gram-Negative Bacteria: Results from a Randomized Clinical Study
  gan: Spyridaki, Aikaterini, et al.
  Cyhoeddwyd: (2012)
• Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis
  gan: Tsaganos, Thomas, et al.
  Cyhoeddwyd: (2016)
• The Importance of Fever as a Predictive Symptom for the Potency of Host's Monocytes to Release Pro- and Anti-Inflammatory Mediators
  gan: Kyriakopoulou, Magdalini, et al.
  Cyhoeddwyd: (2008)